This site requires JavaScript to render the code.

Need to know how to enable JavaScript? Go here.

Sept 2022, automated full molecular cervical cancer screening presented at the ESCV
June 2022, NEW DATA – Methylation performance in pregnant women with CIN3
May 2022, New publication on prognostic value of QIAsure/ PreCursor-M+ Methylation Test for clinical regression of disease
April 2022, NeuMoDx HPV Assay Fulfills the International Guidelines for HPV screening
April 2022, Improved testing method for cervical cancer detection: automated and patient-friendly
November 2021, QIAsure Methylation Test can decrease clinically non relevant colposcopy referrals of hpv positive women with asc-us/ lsil cytology.